VCM
INBX icon

Voleon Capital Management’s Inhibrx INBX Stock Holding History

Voleon Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.64M Buy
39,305
+24,297
+162% +$1.8M 0.06% 289
2025
Q4 		$1.19M Buy
+15,008
New +$1.02M 0.03% 409

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Voleon Capital Management's INBX Position: Q1 2026 in Review

Voleon Capital Management increased its Inhibrx (INBX) stake by 162% in Q1 2026, buying an estimated $1.8M and bringing the position to 39,305 shares worth $2.64M. The position accounts for 0.06% of the portfolio, ranked #289.

Voleon Capital Management first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Voleon Capital Management held 39,305 shares of Inhibrx worth $2.64M as of Q1 2026.
  • Voleon Capital Management bought 24,297 Inhibrx shares in Q1 2026, an estimated $1.8M.
  • Inhibrx made up 0.06% of Voleon Capital Management's portfolio in Q1 2026, its #289 holding.
  • Voleon Capital Management first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.